Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Enrolling by Invitation

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

NCT07072676

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +69 more
Locations: Medical Park, Bad Feilnbach, Reithofpark Bad Feilnbach, Germany

View Trial Details

Not Yet Recruiting

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

NCT07075627

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bronchial Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Effect of Core Strength Training on Wushu C-level Difficulty Movements ,12 Weeks of Core Strength Training

NCT05024071

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Experimental Myasthenia, +7 more
Locations: Ningxia sports vocational and Technical College Yinchuan, Ningxia, China

View Trial Details

Completed

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02970162

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: UCLA Los Angeles, California, United States

View Trial Details

Completed

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

NCT01377922

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
Locations: Birmingham, Alabama, United States

Scottsdale, Arizona, United States

Los Angeles, California, United States

Palo Alto, California, United States

View all 14 locations

View Trial Details

Completed

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

NCT01511978

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Eaton-Lambert Myasthenic Syndrome, +12 more
Locations: University of California at Davis Sacramento, California, United States

Indiana University Indianapolis, Indiana, United States

Duke University Durham, North Carolina, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

NCT00004832

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Disease Attributes, +18 more
Locations: Not specified

View Trial Details

Myasthenia Gravis

Myasthenia Gravis trial results

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Effect of Core Strength Training on Wushu C-level Difficulty Movements ,12 Weeks of Core Strength Training

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

Related conditions